Myomo Inc. (MYO) Financial Statements (2024 and earlier)

Company Profile

Business Address 137 PORTLAND STREET
BOSTON, MA 02114
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5,34615,52412,2414,4656,54112,959
Cash and cash equivalents5,34615,52412,2414,4656,54112,959
Short-term investments      
Other undisclosed cash, cash equivalents, and short-term investments      
Receivables1,8961,960925424382297
Inventory, net of allowances, customer advances and progress billings1,400808707440256201
Inventory1,400808707440256201
Deferred costs     145 
Other undisclosed current assets573894573820551388
Total current assets:9,21519,18714,4466,1497,87413,846
Noncurrent Assets
Operating lease, right-of-use asset509633169 
Property, plant and equipment1942759515518877
Long-term investments and receivables132     
Long-term investments132     
Restricted cash and investments    757552
Other noncurrent assets111     
Other undisclosed noncurrent assets    219145 
Total noncurrent assets:947908264449407129
TOTAL ASSETS:10,16220,09514,7106,5998,28213,975
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3,1793,9502,8491,7381,7431,277
Employee-related liabilities2,1891,8438901,028642
Accounts payable570723180450427265
Accrued liabilities1,780623615256289370
Other undisclosed accounts payable and accrued liabilities830414210143  
Deferred revenue21033
Debt    1,764  
Derivative instruments and hedges, liabilities    378440
Deferred revenue and credits168
Other undisclosed current liabilities40233318 109 
Total current liabilities:3,6024,2832,8703,8841,8561,485
Noncurrent Liabilities
Long-term debt and lease obligation  402155889  
Long-term debt, excluding current maturities    889  
Liabilities, other than long-term debt20111201 44
Deferred revenue and credits44
Deferred revenue 0111
Other liabilities   118   
Operating lease, liability200402155 
Total noncurrent liabilities:201403275890 44
Total liabilities:3,8034,6863,1444,7741,8561,529
Equity
Equity, attributable to parent6,35915,40911,5651,8256,42612,446
Common stock110011
Treasury stock, value(6)(6)(6)(6)(6)(6)
Additional paid in capital95,10593,53879,27457,95751,72147,424
Accumulated other comprehensive income (loss)43(61)(13)   
Accumulated deficit(88,783)(78,062)(67,690)(56,126)(45,290)(34,973)
Other undisclosed equity      
Total equity:6,35915,40911,5651,8256,42612,446
TOTAL LIABILITIES AND EQUITY:10,16220,09514,7106,5998,28213,975

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues15,55513,8567,5833,8382,4441,559
Cost of revenue(5,302)(3,544)(2,600)(918)(728)(505)
Cost of goods and services sold  (113)(457)(491)(530)(410)
Gross profit:10,25310,3124,9832,9201,7161,054
Operating expenses(20,925)(20,580)(15,486)(13,715)(12,244)(7,602)
Operating loss:(10,672)(10,268)(10,503)(10,795)(10,528)(6,548)
Nonoperating income (expense)21(15)(939)82212(5,549)
Other nonoperating income (expense)21(15)(1,061)82212(5,549)
Interest and debt expense(67) (928)(114) (135)
Other undisclosed loss from continuing operations before equity method investments, income taxes      
Loss from continuing operations before equity method investments, income taxes:(10,718)(10,283)(12,369)(10,827)(10,317)(12,233)
Other undisclosed income from continuing operations before income taxes67     
Loss from continuing operations before income taxes:(10,651)(10,283)(12,369)(10,827)(10,317)(12,233)
Income tax expense (benefit)(70)(89)2,5802,9022,636 
Loss from continuing operations:(10,721)(10,372)(9,789)(7,925)(7,681)(12,233)
Loss before gain (loss) on sale of properties:(10,372)(9,789)(7,925)(7,681)(12,233)
Other undisclosed net loss   (1,775)(2,788)(2,636) 
Net loss:(10,721)(10,372)(11,564)(10,713)(10,317)(12,233)
Other undisclosed net income (loss) attributable to parent     135
Net loss attributable to parent:(10,721)(10,372)(11,564)(10,713)(10,317)(12,097)
Preferred stock dividends and other adjustments  (640)671  (562)
Other undisclosed net loss available to common stockholders, basic   (1,341)   
Net loss available to common stockholders, diluted:(10,721)(11,012)(12,235)(10,713)(10,317)(12,659)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(10,721)(10,372)(11,564)(10,713)(10,317)(12,233)
Other comprehensive income (loss)104(48)(13)   
Comprehensive loss, net of tax, attributable to parent:(10,617)(10,420)(11,577)(10,713)(10,317)(12,233)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: